Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.32 | 42.54 |
| PEG Ratio (TTM) | -0.27 | -7.66 |
| P/S Ratio (TTM) | 1.46 | 6.57 |
| P/B Ratio (TTM) | 2.13 | 10.45 |
| P/FCF Ratio (TTM) | 5.22 | 34.85 |
| Price to 5YR AVG Earnings Ratio | 0.01 | 60.27 |
| Price to 5YR AVG FCF Ratio | 0.00 | 45.09 |
Profitability (90%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 21.87% | 12.97% |
| ROE (TTM) | 43.51% | 22.76% |
| Net Profit Margin (TTM) | 28.76% | 17.60% |
| ROIC 5YR AVG | 25.66% | 14.39% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -19.71% | -77.03% | 317.09% |
| Revenue | -8.24% | 10.99% | 23.51% |
| Net Income | -18.70% | -143.82% | 283.85% |
| Cash Flow | -4.51% | 97.70% | 50.22% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.78 | 1.32 |
| Quick Ratio (TTM) | 2.67 | 1.05 |
| D/E Ratio (TTM) | 0.53 | 0.76 |
| Interest Coverage (TTM) | 9.77 | 12.88 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 2.11 | 7.15 |
| LTL to 5YR AVG FCF | 1.27 | 6.46 |
| Shares Outstanding Growth 5YR AVG | 27.94% | 20.31% |